Perinatal Stem Cells: Research and Therapy

— —

Anthony Atala (Professor, Wake Forest Institute for Regenerative Medicine, USA) Kyle J. Cetrulo (Chief Executive Officer, AuxoCell Laboratories, Inc., Cambridge, MA, USA)

Perinatal Stem Cells

Research and Therapy

Anthony Atala (Professor, Wake Forest Institute for Regenerative Medicine, USA), Kyle J. Cetrulo (Chief Executive Officer, AuxoCell Laboratories, Inc., Cambridge, MA, USA), Rouzbeh R. Taghizadeh (Co-Founder, Chief Scientific Officer, AuxoCell Laboratories, Inc., Cambridge, MA, USA) , Curtis L Cetrulo (Assistant Professor, Surgery, Harvard Medical School, Plastic and Reconstructive Surgery, Surgery, Massachusetts General Hospital, USA)

$254.95

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Academic Press Inc
21 June 2018

Materno-fetal medicine; Biomedical engineering

Perinatal Stem Cells provides researchers and clinicians with a comprehensive description of the current clinical and pre-clinical applications of stem cells derived from perinatal sources, such as amniotic fluid, placenta and placental membranes, the umbilical cord and Wharton’s jelly. It's compiled by leading experts in the field, offering readers detailed insights into sources of perinatal stem cells and their potential for disease treatment. Therapeutic applications of perinatal stem cells include the treatment of in utero and pregnancy related diseases, cardiac disease, liver disease, pulmonary disease, inflammatory diseases, for hematopoietic regeneration, and for neural protection after stroke or traumatic brain injury.

In addition, the rapid advance in clinical translation and commercialization of perinatal stem cell therapies is highlighted in a section on Clinical and Industry Perspective which provides insight into the new opportunities and challenges involved in this novel and exciting industry.

Edited by: Anthony Atala (Professor Wake Forest Institute for Regenerative Medicine USA), Kyle J. Cetrulo (Chief Executive Officer, AuxoCell Laboratories, Inc., Cambridge, MA, USA), Rouzbeh R. Taghizadeh (Co-Founder, Chief Scientific Officer, AuxoCell Laboratories, Inc., Cambridge, MA, USA), Curtis L Cetrulo (Assistant Professor, Surgery, Harvard Medical School, Plastic and Reconstructive Surgery, Surgery, Massachusetts General Hospital, USA), Sean Murphy (Assistant Professor, Wake Forest Institute for Regenerative Medicine, USA)
Imprint: Academic Press Inc
Country of Publication: United States
Dimensions: Height: 276mm, Width: 216mm,
Weight: 1.560kg
ISBN: 9780128120156
ISBN 10: 0128120150
Pages: 418
Publication Date: 21 June 2018
Audience: Professional and scholarly , Undergraduate
Format: Hardback
Publisher's Status: Active

Section I. Amniotic Fluid-Derived Stem Cells 1. In utero therapy for congenital disorders using amniotic fluid stem cells 2. The Amniotic Fluid Stem Cell Secretome: at the Heart of Regeneration 3. Transplantation of Amniotic Fluid-Derived Neural Stem Cells 4. Stroke therapy: the potential of amniotic fluid-derived stem cells 5. Vascular formation by human perinatal stem cells 6. Amniotic Fluid Stem Cells for Kidney Regeneration Section II. Placental and Placental Membrane-Derived Stem Cells 7. Placental mesenchymal stem cells for cellular cardiomyoplasty 8. Heterogeneous functions of perinatal mesenchymal stromal cells require a preselection before their banking for clinical use 9. Defining the fetal stem cell niche in the human placenta 10. Banking placental tissue hematopoietic stem cells and mesenchymal stem cells for clinical use 11. Immuno-modulatory mechanisms of placental stem cells 12. Amnion Membrane Allograft for Regenerative Medicine 13. Perinatal cells and biomaterials for wound healing 14. Placental Stem Cells 15. Therapeutic Effect of Extracellular Vesicles Derived from Adult/Perinatal Human Mesenchymal Stem Cells Section III. Umbilical Cord-Derived Cells 16. Ex-vivo Expansion of Cord Blood Stem Cells 17. Cord Blood Transplantation: Therapeutic Use of Perinatal Stem Cells 18. Autologous Human Cord Blood as a Treatment for Traumatic Brain Injury in Children 19. Phenotypic and Functional Characterization Perinatal Stem Cells Isolated from Umbilical Cord Tissue 20. Mesenchymal stromal cells from Wharton’s jelly (WJ-MSCs): coupling their hidden differentiative program with their frank immunomodulatory phenotype 21. Regeneration of ischemic cardiovascular damage using Jelly Wharton as an unlimited source of therapeutic stem cells 22. Phenotype with Focused Paracrine Fractions: Effecting Future Phenotype with Focused Paracrine Fractions Section IV. Clinical and Industry Perspective 23. Clinical Translation of Perinatal Stem Cell Therapy 24. Current Clinical Trials utilizing Perinatal Stem Cells – A Review 25. Review Of Processing Technology and Techniques for Perinatal Stem Cells Banking And Clinical Applications 26. Clinical Development And Commercialization Of Placenta-Derived Cell Therapy 27. How the patent landscape has changed 28. The Need for Better Assays to Predict the Effectiveness of Tissue Stem Cell Treatments

Anthony Atala, MD, is the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine, and the W. Boyce Professor and Chair of Urology. Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medicine. Fifteen applications of technologies developed in Dr. Atala's laboratory have been used clinically. He is Editor of 25 books and 3 journals. Dr. Atala has published over 800 journal articles and has received over 250 national and international patents. Dr. Atala was elected to the Institute of Medicine of the National Academies of Sciences, to the National Academy of Inventors as a Charter Fellow, and to the American Institute for Medical and Biological Engineering. Dr. Atala has led or served several national professional and government committees, including the National Institutes of Health working group on Cells and Developmental Biology, the National Institutes of Health Bioengineering Consortium, and the National Cancer Institute’s Advisory Board. He is a founding member of the Tissue Engineering Society, Regenerative Medicine Foundation, Regenerative Medicine Manufacturing Innovation Consortium, Regenerative Medicine Development Organization, and Regenerative Medicine Manufacturing Society.

WIN $150 GIFT VOUCHERS: ALADDIN'S GOLD

Perinatal Stem Cells

Research and Therapy

$254.95

Hardback

See Also

Contact Abbeys

Contact Galaxy

Contact Language

Contact Us

About ABBEY'S